Mersana Therapeutics (MRSN) Q3 2023 Earnings

7NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.52
-0.46
-0.41
-0.35

Details

Expected EPS
-0.36
Actual EPS
-0.35
Surprise EPS
0.01
Surprise Percent
+2.78%

Description

Mersana Therapeutics (MRSN) has reported earnings of -0.35 per share for Q3 2023.

0 Comments

Share your thoughts